(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Marathon, Amkor Technology, and Coinbase.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Marathon (MARA) | 13.33 | 13.08% | 2023-06-27 14:56:45 |
| 2 | Amkor Technology (AMKR) | 29.52 | 12.01% | 2023-06-27 14:53:15 |
| 3 | Coinbase (COIN) | 68.66 | 10.85% | 2023-06-27 13:48:34 |
| 4 | Redfin (RDFN) | 12.00 | 10.4% | 2023-06-27 14:46:06 |
| 5 | Nio (NIO) | 9.26 | 10.18% | 2023-06-27 13:43:31 |
| 6 | 3D Systems (DDD) | 9.99 | 9.78% | 2023-06-27 13:40:06 |
| 7 | 3D Systems (DDD) | 9.99 | 9.78% | 2023-06-27 13:40:06 |
| 8 | Carnival Plc (CUK) | 14.22 | 9.51% | 2023-06-27 14:49:03 |
| 9 | Generac Holdlings (GNRC) | 143.14 | 9.26% | 2023-06-27 14:50:18 |
| 10 | Canaan (CAN) | 2.21 | 9.16% | 2023-06-27 14:59:47 |
The three biggest losers today are Viking Therapeutics, Walgreens Boots, and Regeneron Pharmaceuticals.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Viking Therapeutics (VKTX) | 14.90 | -17.83% | 2023-06-27 14:46:57 |
| 2 | Walgreens Boots (WBA) | 28.65 | -9.31% | 2023-06-27 14:59:07 |
| 3 | Regeneron Pharmaceuticals (REGN) | 713.34 | -9.06% | 2023-06-27 14:57:53 |
| 4 | Canopy Growth (CGC) | 0.47 | -8.35% | 2023-06-27 14:23:49 |
| 5 | FibroGen (FGEN) | 2.51 | -7.56% | 2023-06-27 14:40:02 |
| 6 | NeuroMetrix (NURO) | 0.91 | -6.82% | 2023-06-27 13:36:01 |
| 7 | Synnex Corporation (SNX) | 91.54 | -6.3% | 2023-06-27 13:15:07 |
| 8 | Rite Aid Corporation (RAD) | 1.80 | -5.26% | 2023-06-27 04:44:09 |
| 9 | Illumina (ILMN) | 183.45 | -4.39% | 2023-06-27 14:56:10 |
| 10 | VerifyMe (VRME) | 1.35 | -4.26% | 2023-06-27 13:37:17 |
Winners today
1. Marathon (MARA) – 13.08%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon jumping 13.08% to $13.33 on Tuesday, following the last session’s downward trend. NASDAQ jumped 1.65% to $13,555.67, after two sequential sessions in a row of losses, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-5.55.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -103.2%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 117.16M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be overbought (>=80).
More news about Marathon.
2. Amkor Technology (AMKR) – 12.01%
Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States, Japan, Europe, the Middle East, Africa, and Asia Pacific. It offers turnkey packaging and test services, including semiconductor wafer bump, wafer probe, wafer back-grind, package design, packaging, system-level and final test, and drop shipment services. The company provides flip chip-scale package products for smartphones, tablets, and other mobile consumer electronic devices; flip-chip stacked chip-scale packages that are used to stack memory digital baseband, and as applications processors in mobile devices; and flip-chip ball grid array packages for various networking, storage, computing, and consumer applications. In addition, it offers wafer-level CSP packages that are used in power management, transceivers, sensors, wireless charging, codecs, radar, and specialty silicon; wafer-level fan-out packages includes power management, transceivers, radar, and specialty silicon for use in ICs; and silicon wafer integrated fan-out technology, which replaces a laminate substrate with a thinner structure. Further, the company provides lead frame packages that are used in electronic devices for low to medium pin count analog and mixed-signal applications; and substrate-based wirebond packages used to connect a die to a substrate. Additionally, it offers micro-electro-mechanical systems (MEMS) packages that are miniaturized mechanical and electromechanical devices; and advanced system-in-package modules, which are used in radio frequency and front end modules, basebands, connectivity, fingerprint sensors, display and touch screen drivers, sensors and MEMS, and NAND memory and solid-state drives. The company primarily serves integrated device manufacturers, fabless semiconductor companies, original equipment manufacturers, and contract foundries. Amkor Technology, Inc. was founded in 1968 and is headquartered in Tempe, Arizona.
NASDAQ ended the session with Amkor Technology rising 12.01% to $29.52 on Tuesday, following the last session’s upward trend. NASDAQ rose 1.65% to $13,555.67, after two sequential sessions in a row of losses, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Amkor Technology has a trailing twelve months EPS of $2.65.
PE Ratio
Amkor Technology has a trailing twelve months price to earnings ratio of 11.14. Meaning, the purchaser of the share is investing $11.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.71%.
Sales Growth
Amkor Technology’s sales growth is negative 1.8% for the ongoing quarter and negative 14.4% for the next.
Yearly Top and Bottom Value
Amkor Technology’s stock is valued at $29.52 at 17:32 EST, below its 52-week high of $31.38 and way above its 52-week low of $14.89.
Moving Average
Amkor Technology’s value is way above its 50-day moving average of $23.85 and way higher than its 200-day moving average of $24.21.
More news about Amkor Technology.
3. Coinbase (COIN) – 10.85%
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. It offers the primary financial account in the cryptoeconomy for consumers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable developers to build crypto-based applications and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase jumping 10.85% to $68.66 on Tuesday, after four successive sessions in a row of gains. NASDAQ jumped 1.65% to $13,555.67, after two sequential sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $-10.78.
Volatility
Coinbase’s last week, last month’s, and last quarter’s current intraday variation average was 2.54%, 0.39%, and 3.96%.
Coinbase’s highest amplitude of average volatility was 3.25% (last week), 4.08% (last month), and 3.96% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Coinbase’s stock is considered to be oversold (<=20).
Sales Growth
Coinbase’s sales growth is negative 49% for the present quarter and 38.3% for the next.
More news about Coinbase.
4. Redfin (RDFN) – 10.4%
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates and sells mortgages. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
NASDAQ ended the session with Redfin jumping 10.4% to $12.00 on Tuesday, following the last session’s upward trend. NASDAQ jumped 1.65% to $13,555.67, after two successive sessions in a row of losses, on what was an all-around up trend exchanging session today.
Earnings Per Share
As for profitability, Redfin has a trailing twelve months EPS of $-2.72.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -173.25%.
Volume
Today’s last reported volume for Redfin is 2921140 which is 5.98% above its average volume of 2756300.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 56.2% and 86.7%, respectively.
More news about Redfin.
5. Nio (NIO) – 10.18%
NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.
NYSE ended the session with Nio rising 10.18% to $9.26 on Tuesday, after five sequential sessions in a row of losses. NYSE jumped 0.82% to $15,646.68, following the last session’s upward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, Nio has a trailing twelve months EPS of $-1.38.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.01%.
Moving Average
Nio’s value is way higher than its 50-day moving average of $8.28 and way below its 200-day moving average of $10.89.
Yearly Top and Bottom Value
Nio’s stock is valued at $9.26 at 17:32 EST, way under its 52-week high of $24.43 and way above its 52-week low of $7.00.
Volume
Today’s last reported volume for Nio is 56805500 which is 9.9% above its average volume of 51685200.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Nio’s EBITDA is 0.28.
More news about Nio.
6. 3D Systems (DDD) – 9.78%
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
NYSE ended the session with 3D Systems jumping 9.78% to $9.99 on Tuesday, following the last session’s upward trend. NYSE jumped 0.82% to $15,646.68, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.
: stratasys’ stock jumps after 3d systems raises cash-and-stock bid, implying 20% premium rose 3.2% in premarket trading Tuesday, after the 3D printer company received a raised buyout bid from 3D Systems Corp. , which 3D Systems said represents meaningful enhancements to its previous bid.
: stratasys to review 3d systems’ raised bid, but still unanimously approves desktop metal merger dealStratasys shareholders do not need to take any action at this time with respect to the 3D Systems revised proposal, Stratasys said in a statement.
Earnings Per Share
As for profitability, 3D Systems has a trailing twelve months EPS of $-0.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.13%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 28.6% and 40%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
3D Systems’s EBITDA is 2.33.
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.8%, now sitting on 526.27M for the twelve trailing months.
More news about 3D Systems.
7. 3D Systems (DDD) – 9.78%
3D Systems Corporation provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers 3D printers technologies, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, polymer extrusion, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental materials, and biocompatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable goods, government, defense, technology, jewelry, electronic, education, consumer goods, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
NYSE ended the session with 3D Systems jumping 9.78% to $9.99 on Tuesday, following the last session’s upward trend. NYSE jumped 0.82% to $15,646.68, following the last session’s upward trend on what was a somewhat up trend exchanging session today.
: stratasys’ stock jumps after 3d systems raises cash-and-stock bid, implying 20% premium rose 3.2% in premarket trading Tuesday, after the 3D printer company received a raised buyout bid from 3D Systems Corp. , which 3D Systems said represents meaningful enhancements to its previous bid.
: stratasys to review 3d systems’ raised bid, but still unanimously approves desktop metal merger dealStratasys shareholders do not need to take any action at this time with respect to the 3D Systems revised proposal, Stratasys said in a statement.
Earnings Per Share
As for profitability, 3D Systems has a trailing twelve months EPS of $-0.94.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.13%.
More news about 3D Systems.
8. Carnival Plc (CUK) – 9.51%
Carnival Corporation & plc engages in the provision of leisure travel services. The company operates a fleet of more than 90 ships visit approximately 700 ports under AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, Princess Cruises, P&O Cruises (Australia), P&O Cruises (UK), and Seabourn brand names. It also provides port destinations and other services, as well as owns and owns and operates hotels, lodges, glass-domed railcars, and motorcoaches. The company sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. It operates in the United States, Canada, Continental Europe, the United Kingdom, Australia, New Zealand, Asia, and internationally. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.
NYSE ended the session with Carnival Plc rising 9.51% to $14.22 on Tuesday while NYSE rose 0.82% to $15,646.68.
Earnings Per Share
As for profitability, Carnival Plc has a trailing twelve months EPS of $-4.06.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.4%.
Moving Average
Carnival Plc’s worth is way higher than its 50-day moving average of $10.27 and way above its 200-day moving average of $8.98.
More news about Carnival Plc.
9. Generac Holdlings (GNRC) – 9.26%
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, energy management devices and solutions, and other power products for the residential, light commercial, and industrial markets worldwide. The company offers residential automatic standby generators, automatic transfer switch, air-cooled engine residential standby generators, and liquid-cooled engine generators; residential storage solution consists of a system of batteries, an inverter, photovoltaic optimizers, power electronic controls, and other components; Mobile Link, a remote monitoring system for home standby generators; smart home solutions, such as smart thermostats and a suite of home monitoring products; smart water heater controllers; residential clean energy solutions; and portable and inverter generators; outdoor power equipment, including trimmers, field and brush mowers, log splitters, stump grinders, chipper shredders, lawn and leaf vacuums, and pressure washers and water pumps; and battery-powered turf care products. It also provides commercial and industrial products comprising cleaner-burning natural gas fueled generators; light-commercial standby generators and related transfer switches; stationary generators and related transfer switches; single-engine industrial generators; industrial standby generators; industrial transfer switches; light towers, mobile generators, and mobile energy storage systems; and aftermarket service parts and product accessories. The company distributes its products through independent residential dealers, industrial distributors and dealers, national and regional retailers, e-commerce partners, electrical, HVAC and solar wholesalers, catalogs, equipment rental companies and distributors, and solar installers; and directly to end users. The company was founded in 1959 and is headquartered in Waukesha, Wisconsin.
NYSE ended the session with Generac Holdlings rising 9.26% to $143.14 on Tuesday, after four sequential sessions in a row of gains. NYSE rose 0.82% to $15,646.68, following the last session’s upward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, Generac Holdlings has a trailing twelve months EPS of $4.09.
PE Ratio
Generac Holdlings has a trailing twelve months price to earnings ratio of 35. Meaning, the purchaser of the share is investing $35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.96%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 61.9% and positive 12.6% for the next.
Yearly Top and Bottom Value
Generac Holdlings’s stock is valued at $143.14 at 17:32 EST, way under its 52-week high of $282.62 and way higher than its 52-week low of $86.29.
Moving Average
Generac Holdlings’s value is way above its 50-day moving average of $112.72 and way above its 200-day moving average of $121.13.
Volatility
Generac Holdlings’s last week, last month’s, and last quarter’s current intraday variation average was 0.24%, 0.70%, and 2.66%.
Generac Holdlings’s highest amplitude of average volatility was 3.31% (last week), 3.01% (last month), and 2.66% (last quarter).
More news about Generac Holdlings.
10. Canaan (CAN) – 9.16%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan rising 9.16% to $2.21 on Tuesday, following the last session’s downward trend. NASDAQ rose 1.65% to $13,555.67, after two consecutive sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.44.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.4%.
Volatility
Canaan’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.05%, a positive 0.37%, and a positive 4.07%.
Canaan’s highest amplitude of average volatility was 4.20% (last week), 3.78% (last month), and 4.07% (last quarter).
Sales Growth
Canaan’s sales growth is negative 68.8% for the ongoing quarter and negative 24.1% for the next.
Moving Average
Canaan’s worth is below its 50-day moving average of $2.42 and way below its 200-day moving average of $2.75.
Revenue Growth
Year-on-year quarterly revenue growth declined by 72.6%, now sitting on 490.93M for the twelve trailing months.
More news about Canaan.
Losers Today
1. Viking Therapeutics (VKTX) – -17.83%
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; VK2735, a novel dual agonist of the glucagon-like peptide, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
NASDAQ ended the session with Viking Therapeutics sliding 17.83% to $14.90 on Tuesday while NASDAQ jumped 1.65% to $13,555.67.
Earnings Per Share
As for profitability, Viking Therapeutics has a trailing twelve months EPS of $-0.79.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.71%.
More news about Viking Therapeutics.
2. Walgreens Boots (WBA) – -9.31%
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
NASDAQ ended the session with Walgreens Boots sliding 9.31% to $28.65 on Tuesday, following the last session’s upward trend. NASDAQ jumped 1.65% to $13,555.67, after two consecutive sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Walgreens Boots has a trailing twelve months EPS of $-3.62.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.56%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 17, 2023, the estimated forward annual dividend rate is 1.92 and the estimated forward annual dividend yield is 6.11%.
More news about Walgreens Boots.
3. Regeneron Pharmaceuticals (REGN) – -9.06%
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat neovascular age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services, as well as with Zai Lab Limited; Intellia Therapeutics, Inc.; Biomedical Advanced Research Development Authority; and AstraZeneca PLC. The company was incorporated in 1988 and is headquartered in Tarrytown, New York.
NASDAQ ended the session with Regeneron Pharmaceuticals falling 9.06% to $713.34 on Tuesday, following the last session’s upward trend. NASDAQ rose 1.65% to $13,555.67, after two successive sessions in a row of losses, on what was an all-around positive trend trading session today.
Earnings Per Share
As for profitability, Regeneron Pharmaceuticals has a trailing twelve months EPS of $37.02.
PE Ratio
Regeneron Pharmaceuticals has a trailing twelve months price to earnings ratio of 19.27. Meaning, the purchaser of the share is investing $19.27 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.27%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is 4.3% and a drop 1.7% for the next.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Regeneron Pharmaceuticals’s stock is considered to be oversold (<=20).
Sales Growth
Regeneron Pharmaceuticals’s sales growth is 6.9% for the present quarter and 8.5% for the next.
Yearly Top and Bottom Value
Regeneron Pharmaceuticals’s stock is valued at $713.34 at 17:32 EST, way under its 52-week high of $837.55 and way higher than its 52-week low of $563.82.
More news about Regeneron Pharmaceuticals.
4. Canopy Growth (CGC) – -8.35%
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
NASDAQ ended the session with Canopy Growth dropping 8.35% to $0.47 on Tuesday while NASDAQ rose 1.65% to $13,555.67.
Earnings Per Share
As for profitability, Canopy Growth has a trailing twelve months EPS of $-4.65.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -151.11%.
More news about Canopy Growth.
5. FibroGen (FGEN) – -7.56%
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
NASDAQ ended the session with FibroGen dropping 7.56% to $2.51 on Tuesday, after three sequential sessions in a row of losses. NASDAQ jumped 1.65% to $13,555.67, after two sequential sessions in a row of losses, on what was an all-around up trend trading session today.
Earnings Per Share
As for profitability, FibroGen has a trailing twelve months EPS of $-0.52.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -411.93%.
Yearly Top and Bottom Value
FibroGen’s stock is valued at $2.51 at 17:32 EST, way below its 52-week low of $10.46.
More news about FibroGen.
6. NeuroMetrix (NURO) – -6.82%
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
NASDAQ ended the session with NeuroMetrix sliding 6.82% to $0.91 on Tuesday while NASDAQ jumped 1.65% to $13,555.67.
Earnings Per Share
As for profitability, NeuroMetrix has a trailing twelve months EPS of $-0.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.76%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NeuroMetrix’s EBITDA is -1.55.
More news about NeuroMetrix.
7. Synnex Corporation (SNX) – -6.3%
TD SYNNEX Corporation operates as a distributor and solutions aggregator for the information technology (IT) ecosystem. The company offers personal computing devices and peripherals, mobile phones and accessories, printers, supplies, and endpoint technology software; and data center technologies, such as hybrid cloud, security, storage, networking, servers, technology software, and converged and hyper-converged infrastructure, as well as computing components. It also provides systems design and rack integration, build-to-order, and configure-to-order assembly; and thermal testing, power-draw testing, burn-in, and quality and logistics support. In addition, the company offers outsourced fulfilment, virtual distribution, and direct ship to end-users; shipping documents generation, multi-level serial number tracking, and configured products and online order and shipment tracking, as well as turn-key logistics solutions. Further, it provides public cloud solutions in productivity and collaboration, IaaS, or Infrastructure as a Service, PaaS, or Platform as a Service, SaaS, or Software as a Service, security, mobility, IoT, and other hybrid solutions. Additionally, the company offers online services; provides net terms, third party leasing, floor plan financing, and letters-of-credit backed financing and arrangement; and leases products and provides device-as-a-service, as well as offers direct mail, external media advertising, reseller product training, targeted telemarketing campaigns, national and regional trade shows, trade groups, database analysis, print on demand services, and web-based marketing. It serves value-added resellers, corporate resellers, government resellers, system integrators, direct marketers, retailers, and managed service providers. The company was formerly known as SYNNEX Corporation and changed its name to TD SYNNEX Corporation in September 2021. TD SYNNEX Corporation was incorporated in 1980 and is headquartered in Fremont, California.
NYSE ended the session with Synnex Corporation dropping 6.3% to $91.54 on Tuesday, after two consecutive sessions in a row of gains. NYSE jumped 0.82% to $15,646.68, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, Synnex Corporation has a trailing twelve months EPS of $7.15.
PE Ratio
Synnex Corporation has a trailing twelve months price to earnings ratio of 12.8. Meaning, the purchaser of the share is investing $12.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.48%.
More news about Synnex Corporation.
8. Rite Aid Corporation (RAD) – -5.26%
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and general merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. In addition, this segment offers healthcare coaching and disease management services to health plans and employers. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.
NYSE ended the session with Rite Aid Corporation falling 5.26% to $1.80 on Tuesday while NYSE jumped 0.82% to $15,646.68.
Earnings Per Share
As for profitability, Rite Aid Corporation has a trailing twelve months EPS of $-13.16.
Yearly Top and Bottom Value
Rite Aid Corporation’s stock is valued at $1.80 at 17:32 EST, way under its 52-week high of $11.61 and higher than its 52-week low of $1.67.
More news about Rite Aid Corporation.
9. Illumina (ILMN) – -4.39%
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
NASDAQ ended the session with Illumina falling 4.39% to $183.45 on Tuesday, after two successive sessions in a row of losses. NASDAQ jumped 1.65% to $13,555.67, after two sequential sessions in a row of losses, on what was an all-around bullish trend trading session today.
Earnings Per Share
As for profitability, Illumina has a trailing twelve months EPS of $-27.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.02%.
Volatility
Illumina’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.33%, a negative 0.11%, and a positive 1.92%.
Illumina’s highest amplitude of average volatility was 1.90% (last week), 1.76% (last month), and 1.92% (last quarter).
Yearly Top and Bottom Value
Illumina’s stock is valued at $183.45 at 17:32 EST, way below its 52-week high of $248.87 and higher than its 52-week low of $173.45.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Illumina’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Illumina is 2188780 which is 60.32% above its average volume of 1365240.
Previous days news about Illumina
- : illumina to lay off workers as part of cost cuts amid icahn fight. According to MarketWatch on Monday, 26 June, "In a filing with the Securities and Exchange Commission, Illumina stated that it began laying off workers on June 21, and expects to continue the cuts into the third quarter. "
More news about Illumina.
10. VerifyMe (VRME) – -4.26%
VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.
NASDAQ ended the session with VerifyMe sliding 4.26% to $1.35 on Tuesday while NASDAQ jumped 1.65% to $13,555.67.
Earnings Per Share
As for profitability, VerifyMe has a trailing twelve months EPS of $-1.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -88%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
VerifyMe’s EBITDA is 0.52.
More news about VerifyMe.
Stay up to date with our winners and losers daily report
